This article is more than 5 years old. Information may no longer be current.
Lung cancer specialist joins Perlmutter Cancer Center
Vamsidhar “Vamsi” Velcheti, MD, joined NYU Langone Health’s Perlmutter Cancer Center as director of thoracic medical oncology.
Velcheti’s research has focused on biomarkers to predict whether patients with lung cancer will respond to immunotherapy. He also serves as principal investigator of an NIH-funded translational research project related to early-stage lung cancer.
“We’re very excited to welcome Dr. Velcheti to our faculty,” Benjamin G. Neel, MD, PhD, director of Perlmutter Cancer Center, said in a press release. “His expertise in immuno-oncology research will strengthen our already impressive lung cancer program.”
Velcheti previously served as associate director of the Center of Immuno-Oncology Research at Cleveland Clinic’s Taussig Cancer Institute.
“It is an honor to join a fantastic institution like Perlmutter Cancer Center,” Velcheti said in a press release. “Lung cancer is a highly complex disease for which most patients require a team approach. With our world-class faculty and facilities, there is immense potential for Perlmutter Cancer Center to be one of the premier centers of excellence in lung cancer.”